Three-year efficacy, overall survival, and safety of ruxolitinib therapy in patients with myelofibrosis from the COMFORT-I study
Ruben A Mesa,Richard S Levy,Vikas Gupta,John F Dipersio,John V Catalano,Carole B Miller,Richard T Silver,Moshe Talpaz,Jimmie H Harvey,Murat O Arcasoy,Elizabeth O Hexner,Azra Raza,Kris Vaddi,W Sun, Wei Peng,Victor Sandor,Hagop Kantarjian,Srdan Verstovsek,Jason Gotlib,Elliott F Winton,Roger M Lyons, Sandor mag(2015)
AI 理解论文
溯源树
样例